Jennifer E. Davoren

1.5k total citations · 1 hit paper
18 papers, 1.1k citations indexed

About

Jennifer E. Davoren is a scholar working on Organic Chemistry, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Jennifer E. Davoren has authored 18 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Organic Chemistry, 8 papers in Molecular Biology and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Jennifer E. Davoren's work include Asymmetric Synthesis and Catalysis (4 papers), Receptor Mechanisms and Signaling (4 papers) and Neuroscience and Neuropharmacology Research (3 papers). Jennifer E. Davoren is often cited by papers focused on Asymmetric Synthesis and Catalysis (4 papers), Receptor Mechanisms and Signaling (4 papers) and Neuroscience and Neuropharmacology Research (3 papers). Jennifer E. Davoren collaborates with scholars based in United States, Russia and China. Jennifer E. Davoren's co-authors include Peter Wipf, Valerian E. Kagan, Adam T. Hoye, Mitchell P. Fink, Martin Gruebele, Deguo Du, Amelia A. Fuller, Jeffery W. Kelly, Stephen F. Martin and Jon Bordner and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Nature Communications.

In The Last Decade

Jennifer E. Davoren

17 papers receiving 1.1k citations

Hit Papers

Targeting Mitochondria 2008 2026 2014 2020 2008 100 200 300 400 500

Peers

Jennifer E. Davoren
Adam T. Hoye United States
Minseob Koh South Korea
Xue Yang China
Hogyu Han South Korea
Adam T. Hoye United States
Jennifer E. Davoren
Citations per year, relative to Jennifer E. Davoren Jennifer E. Davoren (= 1×) peers Adam T. Hoye

Countries citing papers authored by Jennifer E. Davoren

Since Specialization
Citations

This map shows the geographic impact of Jennifer E. Davoren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer E. Davoren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer E. Davoren more than expected).

Fields of papers citing papers by Jennifer E. Davoren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennifer E. Davoren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer E. Davoren. The network helps show where Jennifer E. Davoren may publish in the future.

Co-authorship network of co-authors of Jennifer E. Davoren

This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer E. Davoren. A scholar is included among the top collaborators of Jennifer E. Davoren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer E. Davoren. Jennifer E. Davoren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Kozak, Rouba, Tamás Kiss, David E. Johnson, et al.. (2020). Characterization of PF-6142, a Novel, Non-Catecholamine Dopamine Receptor D1 Agonist, in Murine and Nonhuman Primate Models of Dopaminergic Activation. Frontiers in Pharmacology. 11. 1005–1005. 18 indexed citations
2.
Gray, David, John Allen, Scot Mente, et al.. (2018). Impaired β-arrestin recruitment and reduced desensitization by non-catechol agonists of the D1 dopamine receptor. Nature Communications. 9(1). 674–674. 75 indexed citations
3.
Davoren, Jennifer E., Deane M. Nason, Jotham W. Coe, et al.. (2018). Discovery and Lead Optimization of Atropisomer D1 Agonists with Reduced Desensitization. Journal of Medicinal Chemistry. 61(24). 11384–11397. 38 indexed citations
4.
Smith, Deborah L., Jennifer E. Davoren, Jeremy R. Edgerton, et al.. (2016). Characterization of a Novel M1 Muscarinic Acetylcholine Receptor Positive Allosteric Modulator Radioligand, [3H]PT-1284. Molecular Pharmacology. 90(3). 177–187. 4 indexed citations
5.
Popiolek, Michael, David P. Nguyen, Veronica Reinhart, et al.. (2016). Inositol Phosphate Accumulation in Vivo Provides a Measure of Muscarinic M1 Receptor Activation. Biochemistry. 55(51). 7073–7085. 11 indexed citations
6.
Hoye, Adam T., Jennifer E. Davoren, Peter Wipf, Mitchell P. Fink, & Valerian E. Kagan. (2012). Correction to Targeting Mitochondria. Accounts of Chemical Research. 45(12). 2222–2222. 20 indexed citations
7.
Davoren, Jennifer E., et al.. (2012). Measurement of Atropisomer Racemization Kinetics Using Segmented Flow Technology. ACS Medicinal Chemistry Letters. 3(5). 433–435. 16 indexed citations
8.
Harris, Anthony R., Deane M. Nason, Wenjian Xu, et al.. (2011). Synthesis of 5-bromo-6-methyl imidazopyrazine, 5-bromo and 5-chloro-6-methyl imidazopyridine using electron density surface maps to guide synthetic strategy. Tetrahedron. 67(47). 9063–9066. 10 indexed citations
9.
Davoren, Jennifer E., et al.. (2011). Scalable Synthesis of 4-Substituted 5-Bromo-6-methylpyrimidines. Synthesis. 2011(10). 1529–1531. 1 indexed citations
10.
Davoren, Jennifer E., David Gray, Anthony R. Harris, Deane M. Nason, & Wenjian Xu. (2010). Remarkable [3+2] Annulations of Electron-Rich Olefins with Unstabilized Azomethine Ylides. Synlett. 2010(16). 2490–2492. 19 indexed citations
11.
Fuller, Amelia A., Deguo Du, Feng Liu, et al.. (2009). Evaluating β-turn mimics as β-sheet folding nucleators. Proceedings of the National Academy of Sciences. 106(27). 11067–11072. 86 indexed citations
12.
Du, Deguo, Amelia A. Fuller, Jennifer E. Davoren, et al.. (2008). An experimental survey of the transition between two-state and downhill protein folding scenarios. Proceedings of the National Academy of Sciences. 105(7). 2369–2374. 132 indexed citations
13.
Davoren, Jennifer E., Christian Harcken, & Stephen F. Martin. (2008). ChemInform Abstract: Studies Toward the Enantioselective Syntheses of Oxylipins: Total Synthesis and Structure Revision of Solandelactone E.. ChemInform. 39(20). 1 indexed citations
14.
Hoye, Adam T., Jennifer E. Davoren, Peter Wipf, Mitchell P. Fink, & Valerian E. Kagan. (2008). Targeting Mitochondria. Accounts of Chemical Research. 41(1). 87–97. 562 indexed citations breakdown →
15.
Davoren, Jennifer E., Christian Harcken, & Stephen F. Martin. (2007). Studies toward the Enantioselective Syntheses of Oxylipins:  Total Synthesis and Structure Revision of Solandelactone E. The Journal of Organic Chemistry. 73(2). 391–402. 26 indexed citations
16.
Davoren, Jennifer E. & Stephen F. Martin. (2006). Enantioselective Synthesis and Structure Revision of Solandelactone E. Journal of the American Chemical Society. 129(3). 510–511. 32 indexed citations
17.
Burvill, Colin, et al.. (2005). The Design of Self Evolving Behaviour: Self-evolution I. 1624.
18.
Liras, Spiros, Jennifer E. Davoren, & Jon Bordner. (2001). An Approach to the Skeleton of the Securinega Alkaloids. The Total Synthesis of (±)-Securinine. Organic Letters. 3(5). 703–706. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026